Calian Group (TSE:CGY – Free Report) had its price objective hoisted by CIBC from C$50.00 to C$59.00 in a report issued on Monday,BayStreet.CA reports.
A number of other equities analysts have also recently issued reports on the stock. Canaccord Genuity Group dropped their price target on shares of Calian Group from C$75.00 to C$60.00 and set a “buy” rating on the stock in a research note on Thursday, May 22nd. Royal Bank Of Canada dropped their price target on shares of Calian Group from C$60.00 to C$58.00 and set an “outperform” rating on the stock in a research note on Thursday, May 22nd. Ventum Financial set a C$60.00 target price on Calian Group and gave the stock a “buy” rating in a research report on Wednesday, June 11th. Finally, Desjardins boosted their target price on Calian Group from C$61.00 to C$62.00 and gave the stock a “buy” rating in a research report on Wednesday, July 9th.
Get Our Latest Research Report on CGY
Calian Group Stock Performance
Calian Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, June 10th. Stockholders of record on Tuesday, June 10th were given a dividend of $0.28 per share. The ex-dividend date of this dividend was Tuesday, May 27th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 2.16%. Calian Group’s dividend payout ratio is currently 119.93%.
Insider Transactions at Calian Group
In related news, Senior Officer Kevin Lee Ford purchased 1,000 shares of the stock in a transaction that occurred on Monday, May 26th. The stock was bought at an average cost of C$38.05 per share, for a total transaction of C$38,050.00. Insiders acquired 2,934 shares of company stock valued at $116,566 in the last ninety days. 0.63% of the stock is owned by company insiders.
About Calian Group
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.
Further Reading
- Five stocks we like better than Calian Group
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Domino’s Delivers Another Discounted Entry for Income Investors
- Earnings Per Share Calculator: How to Calculate EPS
- TSLA Earnings Week: Can Tesla Break Through $350?
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Goldman, Morgan Stanley, & BofA: Diverging Paths After Earnings
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.